NASDAQ2140.13 (+0.66%)
S&P 5001067.48 (+1.02%)

Financial News Discussion of GILD - Gilead Sciences, Incorporated on Mad Money

Financial News for Gilead Sciences, Incorporated (GILD)

GILD 2/9/2010 11:09AM 52 Week Price Range Market Capitalization Dividend Yield Recent Dividend
$46.24 $40.62 — $50.00 $41.5 Billion n/a n/a

Want to Sharpen Your Investing?

Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.

Sign Up Now for Ockham's Stock Analysis and News Services

Explore Why Ockham?

Quality Analysis
Ockham has fundamental valuations on over 5000 companies which we distribute, to our clients via highly-focused equity reports, weekly newsletters, and analysts' daily market commentary blogs. (Learn More)
Crowd Sentiment
Through our partnership with The Motley Fool, Ockham provides the most robust data on investors' sentiment of individual stocks. This indicator, along with our valuations and our news tracking, helps our clients make informed investment decisions. (Learn More)
Financial News Slicing
With the influx of noise in our lives, it can be exceedingly difficult to separate the essential news from everything else. Ockham's RazorWire tool "slices" through business television and impactful blogs to provide you with the clearest information possible. (Learn More)
Gilead Sciences, Inc. was discussed on Mad Money which was originally produced by CNBC on 9/9/2009
Gilead Sciences, Incorporated was discussed on Mad Money with host, Jim Cramer, on 9/9/09. Mad Money airs on CNBC each business day at 6:00 PM.

Gilead Sciences, Incorporated is in the news. Find out how this impacts GILD trading on Ockham Research.

I used to trade biochris, they haven't made any money. These have soared not because of swine flu but swine flu hype. So who do I think is the swine flu winner? GILEAD, GILD. Biotech stock i've owned for a long time in my charitable it gets 80% of its sales from its fabulous hiv franchise. But it also earns royalties on the sales of tamiflu. Which swine flu has only been resistant to in rare cases. This one's it. Tamiflu royalties are reported on a one quarter lag, which means you can get into GILEAD it's barely moved. Before swine flu hits the its tamiflu royalties are on a sliding scale. The more of the drug that gets sold, the higher the royalties. Sought first 200 million of sales, that's 14% GILEAD gets, it gets 22% of everything once tamiflu sales break through the 400 million mark. In 2007 tamiflu made it up to 17% of GILEAD's operating product kurt zif avian flu. Last year it was just 5%. Given that this is another strong flu year with swine flu coming on strong and we're stockpiling tamiflu left and right, I really think it has the power to move the numbers and thus more GILEAD's stock, which again has flat-lined much here's the bottom line. I don't want you gambling on the president's nfl-like health care strategy. It's too hard. The line's all figured out. He's going for the field goal. Instead of the gambling on a field goal, invest in whatever has a chance of beating swine flu. Which means invest in GILEAD. Let's take calls. Let's go to poliz in kentucky. >> caller: hi, jim. A bluegrass boo-yah to you. >> well, man, I just like that kind of regional -- ooh. >> caller: the obama situation, will health care get a boost or will it tank?

“es from its fabulous hiv franchise. But it also earns royalties on the sales of tamiflu. Which swine flu has only been resistant to in rare cases. This one's it. Tamiflu royalties are reported on a one quarter lag, which means you can get into GILEAD it's barely moved. Before swine flu hits the its tamiflu royalties are on a sliding scale. The more of the drug that gets sold, the higher the royalties. Sought first 200 million of sales, that's 14% GILEAD gets, it gets 22% of everything once tamiflu sales break through the 400 million mark. In 2007 tamiflu made it up to 17% of GILEAD's operating product kurt zif avian flu. Last year it was just 5%. Given that this is another strong flu year with swine flu coming on strong and we're stockpiling tamiflu left and right, I really think it has the power to move the numbers and thus more GILEAD's stock, which again has flat-lined much here's the bottom line. I don't want you gambling on the president's nfl-like health care strategy. It's too hard. The line's all figured out. He's going for the field goal. Instead of the gambling on a field goal, invest in whatever has a chance of beating swine flu. Which means invest in GILEAD. Let's take calls. Let's go to poliz in kentucky.
caller: hi, jim. A bluegrass boo-yah to you.
well, man, I just like that kind of regional -- ooh.
caller: the obama situation, will health care get a boost or will it tank? ” Mad Money Sep 9, 2009 6:08 PM
A couple other items to be aware of:
  • Since the stock was mentioned on Mad Money on Wednesday, September 09, 2009, GILD shares have decreased by 3.34%.
  • Please visit the Mad Money recap page for all the slices of the 32 stocks mentioned on just this one episode of the show.
  • This was the only mention for Gilead Sciences, Incorporated on this show, but you can see all other stocks mentioned by Jim Cramer on Mad Money by visiting the Mad Money recap.
  • Besides Gilead Sciences, Incorporated's mention on Mad Money it's also been discussed 33 times on various other business shows since then. You can also catch up on All financial news for Gilead Sciences, Incorporated.
  • Interestingly, Apple, Incorporated is the most often mentioned stock on Mad Money, over the last 2 weeks.